Allotment of 25.2 Lakh Equity Shares on Warrant Conversion

Warrants ConvertedFund Raising View source PDF Explain this filing

AAREYDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹83.94

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-1.5% vs market

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-1.5+0.0-1.5

Next day

+0.3-0.0+0.3

-2.7-0.2-2.5

-1.1+0.2-1.3

+1.1+0.3+0.8

-1.1+0.4-1.5

-1.1+0.9-2.0

15d

+6.0+1.6+4.5

+13.2+2.0+11.2

+26.9+0.6+26.4

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarey Drugs board allotted 25,20,000 equity shares (face value Rs. 10) on conversion of warrants at Rs. 63.80 per share, collecting Rs. 12.06 crore as the remaining 75 percent payment. Paid-up capital rises from 2.83 crore to 3.34 crore shares. All converted warrants went to promoter group members of the Ghatalia family. 24,80,000 warrants remain outstanding with non-promoter allottees, convertible within 18 months from May 2025.

Likely market impact

Minor dilution with promoter group increasing stake. Rs. 12 crore inflow to company. Remaining 24.8 lakh warrants may cause further dilution.